MONT-SAINT-HILAIRE, QUEBEC -- (MARKET WIRE) -- May 15, 2007 -- Axcan Pharma Inc. (“Axcan” or the “Company”) (TSX: AXP)(NASDAQ: AXCA) today announced today it has called for redemption on June 29, 2007, all of its US $125 million aggregate principal amount 4.25% Convertible Notes Due 2008 (the “Notes”). The Notes were originally issued in 2003.
